ArticlePLoS neglected tropical diseases2026
Long-term spatio-temporal trends in burden of fungal skin diseases in middle-aged and elderly people from 1990 to 2021.
Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAs a high incidence group, the elderly face the burden of fungal skin diseases, which has remained poorly quantified. This study aims to analyse the spatiotemporal trends in the burden of fungal skin diseases in middle-aged and elderly people from 1990 to 2021.
methodsData were obtained from the Global Burden of Disease (GBD) Study 2021. This study analysed incident cases, prevalent cases, disability-adjusted life years (DALYs), and their corresponding rates for fungal skin diseases in middle-aged and elderly people stratified by sex, age, socio-demographic index (SDI), GBD regions, and countries. Average annual percent change (AAPC) was calculated to assess temporal trends in the burden of fungal skin diseases.
resultsFrom 1990 to 2021, the global incidence, prevalence, and DALYs rates of fungal skin diseases in middle-aged and elderly people were consistently higher than those in the entire population. Globally, incident cases, prevalent cases, and DALYs of fungal skin diseases in middle-aged and elderly people increased by 124.09%, 124.13%, and 123.26%, respectively. In 2021, the incidence, prevalence, and DALYs rates were 38255.44 (95% uncertainty interval [UI]: 32832.61-44492.76), 12186.46 (95% UI: 10721.21-14030.06), and 64.66 (95% UI: 26.34-133.26) per 100,000 population, respectively. From 1990 to 2021, the incidence, prevalence, and DALYs rates exhibited overall upward trends, with AAPCs of 4.12% (95% confidence interval [CI]: 3.04%-5.20%), 4.18% (95% CI: 3.11%-5.24%), and 2.89% (95% CI: 1.89%-3.89%), respectively. Geographically, the highest burden was concentrated in Andean Latin America, Australasia, and Western Europe.
conclusionsThe global burden of fungal skin diseases in middle-aged and elderly people has increased over the past three decades, with significant disparities across sexes, SDI levels, regions, and countries. Targeted public health interventions and resource allocation are required to reduce the burden of fungal skin diseases in this vulnerable population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.